Removing your gallbladder may increase colorectal cancer risk, particularly in women and in the upper colon, with peak incidence occurring 5-15 years after surgery. According to Gram Research analysis, the surgery disrupts gut bacteria and bile acid processing, suppressing a protective cellular signal called FXR that normally prevents cancer. Mediterranean diet, probiotics, and emerging medications targeting FXR may help reduce this risk.
According to Gram Research analysis, removing your gallbladder—one of the world’s most common surgeries—may increase the risk of colorectal cancer, particularly in the upper part of the colon. Scientists have discovered that when the gallbladder is removed, it changes the bacteria living in your gut and how your body processes bile acids, which are digestive fluids. These changes can interfere with a protective cellular signal called FXR, potentially allowing cancer to develop. A new review synthesizes decades of research to explain why this happens and proposes personalized prevention strategies, including dietary changes and targeted medications, to help protect people who’ve had this surgery.
Key Statistics
A 2026 review in the Journal of the Egyptian National Cancer Institute found that cholecystectomy consistently increases colorectal cancer risk with predominance in the proximal colon and higher incidence in women, with peak risk occurring 5-15 years post-surgery.
Research shows that cholecystectomy decreases beneficial gut bacteria like Bifidobacterium breve while increasing potentially harmful Ruminococcus gnavus, changes that suppress FXR signaling and promote colorectal carcinogenesis.
A 2025 Nature Communications study demonstrated that cholecystectomy-induced microbiota shifts alter bile acids, suppress FXR, disrupt protective FXR/β-catenin interaction, and promote tumorigenesis in preclinical models.
The Quick Take
- What they studied: Whether removing the gallbladder increases colorectal cancer risk and why this happens at the cellular level
- Who participated: This is a review article that analyzed existing research studies on cholecystectomy (gallbladder removal) and colorectal cancer risk across multiple populations, primarily showing higher risk in women with peak incidence 5-15 years after surgery
- Key finding: Cholecystectomy causes specific changes in gut bacteria and bile acids that suppress a protective cellular signal (FXR), with cancer risk appearing highest in the upper colon and affecting women more than men
- What it means for you: If you’ve had your gallbladder removed, you may benefit from preventive strategies like Mediterranean diet, specific probiotics, or medications that restore the protective FXR signal—though more research is needed to confirm which interventions work best
The Research Details
This is a comprehensive review article that synthesizes existing epidemiological studies and laboratory research on gallbladder removal and colorectal cancer. Rather than conducting a new experiment, the authors analyzed patterns from multiple previous studies to identify consistent findings and explain the biological mechanisms behind them.
The review focuses on three main areas: (1) epidemiological evidence showing that gallbladder removal increases colorectal cancer risk, particularly in women and in the upper portion of the colon; (2) the specific changes in gut bacteria and bile acids that occur after surgery; and (3) how these changes affect a cellular communication system called the FXR signaling pathway, which normally protects against cancer development.
By organizing existing knowledge this way, the authors created a framework for understanding why this surgery increases cancer risk and identified potential prevention strategies based on restoring normal gut function.
Review articles are important because they synthesize scattered research findings into a coherent picture. In this case, previous studies showed conflicting results about whether gallbladder removal truly increases cancer risk. By organizing all available evidence, this review reveals consistent patterns that were previously unclear. Understanding the biological mechanism—how the surgery changes gut bacteria and disrupts protective cellular signals—transforms this from a mysterious correlation into an actionable health issue with potential solutions.
This review was published in a peer-reviewed journal and synthesizes recent research including a 2025 Nature Communications study that provided key mechanistic insights. The authors acknowledge that while epidemiological patterns are consistent, most interventions (like FXR agonist medications) remain experimental. The review appropriately distinguishes between what’s proven in humans versus what’s shown in laboratory studies, and identifies gaps where more research is needed.
What the Results Show
Research shows that people who have their gallbladder removed face a measurably increased risk of colorectal cancer, with several consistent patterns emerging across studies. The cancer risk appears highest in the upper portion of the colon (proximal colon), differs between sexes with women showing higher risk than men, and typically develops 5-15 years after the surgery.
The mechanism behind this increased risk involves three interconnected changes: First, the surgery alters the composition of bacteria living in the gut, specifically decreasing beneficial bacteria like Bifidobacterium breve while increasing potentially harmful bacteria like Ruminococcus gnavus. Second, these bacterial changes disrupt the normal processing of bile acids—digestive fluids that normally help protect the colon. Third, these changes suppress a protective cellular signal called FXR (farnesoid X receptor), which normally prevents cancer development.
A landmark 2025 study demonstrated that when FXR signaling is suppressed, it disrupts another protective pathway involving β-catenin, allowing cancer-promoting processes to accelerate. This explains why the surgery increases cancer risk at the molecular level—it’s not random, but rather a predictable consequence of disrupting the gut’s protective systems.
The review identifies that bile acid composition changes specifically after gallbladder removal, with elevated levels of certain bile acids (TUDCA and GUDCA) while protective bile acids decrease. These changes are directly linked to the bacterial composition shifts. Additionally, the research suggests that the cancer risk isn’t uniform across all individuals—demographic factors like sex and age at surgery, combined with individual differences in gut bacteria and metabolism, likely determine who faces the highest risk.
Earlier research on gallbladder removal and cancer risk produced conflicting results, with some studies showing increased risk and others showing no association. This review resolves much of that controversy by demonstrating that the increased risk is real and consistent, but was sometimes missed because researchers weren’t looking at the right populations (women, proximal colon) or the right timeframe (5-15 years post-surgery). The mechanistic insights from recent molecular studies explain why previous epidemiological observations actually make biological sense.
This is a review article synthesizing existing research rather than a new study, so it’s limited by the quality and scope of previously published work. Most interventions discussed—like FXR agonist medications—have only been tested in laboratory settings or animal models, not yet proven safe and effective in humans. The review acknowledges that while epidemiological patterns are consistent, individual risk varies greatly and we cannot yet predict who will develop cancer after gallbladder removal. Additionally, most research has focused on Western populations, so findings may not apply equally to all ethnic groups.
The Bottom Line
For people who’ve had their gallbladder removed: (1) Adopt a Mediterranean-style diet rich in vegetables, whole grains, and healthy fats—this supports beneficial gut bacteria and has strong evidence for cancer prevention; (2) Discuss with your doctor whether probiotic supplements containing beneficial bacteria might be appropriate for your situation; (3) Maintain regular colorectal cancer screening as recommended for your age and risk level; (4) Ask your doctor about emerging FXR-targeted medications if you have additional risk factors. These recommendations have varying levels of evidence, with diet being most established and newer medications still experimental.
This research is most relevant for people who have had or are considering gallbladder removal surgery, particularly women and those with family histories of colorectal cancer. Healthcare providers should consider this information when counseling patients about gallbladder surgery risks and benefits. People who had their gallbladder removed more than 5 years ago should be especially attentive to colorectal cancer screening. Those with recent gallbladder removal have time to implement preventive strategies before peak risk periods.
Colorectal cancer typically develops 5-15 years after gallbladder removal, so this is a medium-term risk rather than an immediate concern. Dietary and lifestyle changes can be implemented immediately and may reduce risk over months to years. If new medications become available, their protective effects would likely take months to years to demonstrate. Regular screening should begin based on standard guidelines and individual risk factors.
Frequently Asked Questions
Does gallbladder removal increase colon cancer risk?
Research shows gallbladder removal does increase colorectal cancer risk, particularly in women and the upper colon, with peak incidence 5-15 years after surgery. The surgery disrupts gut bacteria and bile acid processing, suppressing protective FXR signaling.
What changes happen in the gut after gallbladder removal?
Cholecystectomy decreases beneficial bacteria like Bifidobacterium breve while increasing potentially harmful bacteria like Ruminococcus gnavus. These changes disrupt bile acid processing and suppress FXR, a protective cellular signal against cancer development.
Can diet prevent colon cancer after gallbladder removal?
Mediterranean diet shows strong evidence for cancer prevention and supports beneficial gut bacteria. Adopting this diet—rich in vegetables, whole grains, and healthy fats—may reduce cancer risk after gallbladder removal, though more research is needed.
How long after gallbladder removal does colon cancer risk increase?
Colorectal cancer risk peaks 5-15 years after gallbladder removal. This timeframe allows opportunity for preventive strategies like dietary changes and screening before highest-risk periods.
Are there medications to prevent colon cancer after gallbladder removal?
FXR agonist medications like obeticholic acid show promise in laboratory studies by restoring protective signaling, but remain experimental in humans. Gut-restricted versions are being developed to avoid systemic side effects.
Want to Apply This Research?
- Track weekly servings of Mediterranean diet components (vegetables, whole grains, fish, olive oil) and colorectal cancer screening dates. Users who’ve had gallbladder removal can set reminders for screening appointments and monitor dietary adherence to evidence-based cancer prevention patterns.
- Users can log daily meals to increase Mediterranean diet adherence, set weekly goals for vegetable and fiber intake, and receive notifications about colorectal cancer screening milestones. The app could provide specific meal suggestions that support gut health while tracking compliance over time.
- Establish a baseline of current diet quality and screening status, then monitor quarterly progress toward Mediterranean diet goals and annual screening compliance. For users taking probiotics or future FXR-targeted medications, the app could track adherence and any gastrointestinal symptoms to discuss with healthcare providers.
This review synthesizes existing research on the relationship between gallbladder removal and colorectal cancer risk. While epidemiological patterns are consistent, individual risk varies greatly and cannot be predicted with certainty. Most proposed interventions—particularly FXR-targeted medications—remain experimental and have not been proven safe and effective in humans. This information is for educational purposes and should not replace personalized medical advice. Anyone who has had gallbladder removal should discuss their individual cancer risk and appropriate screening protocols with their healthcare provider. Do not start new supplements or medications without consulting your doctor.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.